Effect of axial coordination on the electronic structure and biological activity of dirhodium(II,II) complexes

Ru(II) Complexes with Absorption in the Photodynamic Therapy Window: 1O2 Sensitization, DNA Binding, and Plasmid DNA Photocleavage

Two Ru(II) complexes, [Ru(pydppn)(bim)(py)]2+ [2; pydppn = 3-(pyrid-2'-yl)-4,5,9,16-tetraaza-dibenzo[a,c]naphthacene; bim = 2,2'-bisimidazole; py = pyridine] and [Ru(pydppn)(Me4bim)(py)]2+ [3; Me4bim = 2,2'-bis(4,5-dimethylimidazole)], were synthesized and characterized, and their photophysical properties, DNA binding, and photocleavage were evaluated and compared to [Ru(pydppn)(bpy)(py)]2+ (1; bpy = 2,2'-bipyridine). Complexes 2 and 3 exhibit broad 1MLCT (metal-to-ligand charge transfer) transitions with maxima at ∼470 nm and shoulders at ∼525 and ∼600 nm that extend to ∼800 nm. These bands are red-shifted relative to those of 1, attributed to the π-donating ability of the bim and Me4bim ligands. A strong signal at 550 nm is observed in the transient absorption spectra of 1-3, previously assigned as arising from a pydppn-centered 3ππ* state, with lifetimes of ∼19 μs for 1 and 2 and ∼270 ns for 3. A number of methods were used to characterize the mode of binding of 1-3 to DNA, including absorption titrations, thermal denaturation, relative viscosity changes, and circular dichroism, all of which point to the intercalation of the pydpppn ligand between the nucleobases. The photocleavage of plasmid pUC19 DNA was observed upon the irradiation of 1-3 with visible and red light, attributed to the sensitized generation of 1O2 by the complexes. These findings indicate that the bim ligand, together with pydppn, serves to shift the absorption of Ru(II) complexes to the photodynamic therapy window, 600-900 nm, and also extend the excited state lifetimes for the efficient production of cytotoxic singlet oxygen.

Digging into protein metalation differences triggered by fluorine containing-dirhodium tetracarboxylate analogues

Catalytic and biological properties of dirhodium tetracarboxylates ([Rh2(μ-O2CR)4L2], L=axial ligand, R=CH3-, CH3CH2-, etc) largely depend on the nature of the bridging carboxylate equatorial μ-O2CR ligands, which can be easily exchanged...

Stable thiolate adducts of Rh2(OAc)4 - assembly of hexametallic Ni4Rh2 complexes

Thiolate adducts of dirhodium(II) tetraacetate have proven difficult to prepare. We isolated a stable, paramagnetic Ni₄Rh₂ adduct containing Ni-based metallothiolates bound in axial positions of the Rh₂⁴⁺ core. The adduct formation is accompanied by a change of the magnetic exchange interaction in the dinuclear Ni₂ subunits.

Heteroleptic dirhodium(II,II) paddlewheel complexes as carbene transfer catalysts

This review highlights the applications of dirhodium(II,II) paddlewheel complexes with a heteroleptic scaffold. Dirhodium(II,II) paddlewheel complexes are well known as highly efficient and selective carbene transfer catalysts. While the majority of described complexes are homoleptic, comparatively fewer studies have concerned heteroleptic complexes. Here, we emphasise the use of heteroleptic complexes in order to highlight their benefits as carbene transfer catalysts and spur future research. Methods to synthesise heteroleptic dirhodium(II,II) paddlewheel complexes are discussed as well as a categorical review of their types of heteroleptic complexes and the carbene reactions in which they have been used.

Binding of histidine and human serum albumin to dirhodium(II) tetraacetate

Reactions of the anticancer active dirhodium tetraacetate (1), Rh₂(AcO)₄ (AcO^- = CH₃COO^-), with the amino acid histidine (HHis) and human serum albumin (HSA) were monitored over time and different metal: ligand ratios using UV-vis spectroscopy and/or electro-spray ionization mass spectrometry. Initially, histidine formed 1:1 and 1:2 adducts in aqueous solutions. The crystal structure of Rh₂(AcO)₄(L-HHis)₂·2H₂O (2) confirmed the axial coordination of histidine imidazole groups (average Rh-N_axial 2.23 Å). These adducts, however, were found to be unstable in solution over time (24 h). Heating Rh₂(AcO)₄ -histidine solutions to 40 °C (near body temperature) or 95 °C accelerated the formation of Rh^II₂(AcO)₂(His)₂ and Rh^III(His)₂(AcO) complexes. The corresponding pH change from neutral to mildly acid (pH 4-5) indicates deprotonation of histidine NH₃⁺ groups due to coordination to Rh ions, which simultaneously bind to histidine COO^- groups, as evidenced by ¹³C NMR spectroscopy. In the case of HSA with 16 histidine and one cysteine residues, UV-vis spectroscopy indicates that mono- and di-histidine HSA adducts with Rh₂(AcO)₄ are formed. X-ray absorption spectroscopy showed almost the same Rh-Rh distance (2.41 ± 0.01 Å) for the Rh₂(AcO)₄ units as in 2, and a contribution from an axial thiol coordination (Rh-S_axial 2.62 ± 0.05 Å). The Rh₂(AcO)₄ - HSA complex was found to decompose partially (~15%) over 24 h at ambient temperature. The partial decomposition of Rh₂(AcO)₄ both through coordination to histidine or to human serum albumin, the most abundant protein in blood plasma, is a factor to consider for its efficacy as a potential anticancer agent.

Synthetic Strategies for Trapping the Elusive trans-Dirhodium(II,II) Formamidinate Isomer: Effects of Cis versus Trans Geometry on the Photophysical Properties

The cis- and trans-dirhodium(II,II) complexes cis-[Rh₂(μ-DTolF)₂(μ-np)(MeCN)₄][BF₄]₂ (1; DTolF = N,N'-di-p-tolylformamidinate and np = 1,8-naphthyridine), cis- and trans-[Rh₂(μ-DTolF)₂(μ-qxnp)(MeCN)₃][BF₄]₂ [2 and 3, respectively, where qxnp = 2-(1,8-naphthyridin-2-yl)quinoxaline], and trans-[Rh₂(μ-DTolF)₂(μ-qxnp)₂][BF₄]₂ (4) were synthesized and characterized. A new synthetic methodology was developed that consists of the sequential addition of π-accepting axially blocking ligands to favor formation of the first example of a bis-substituted formamidinate-bearing trans product. Isolation of the intermediates 2 and 3 provides insight into the mechanistic requirements for obtaining 4 and the cis analogue, cis-[Rh₂(μ-DTolF)₂(μ-qxnp)₂][BF₄]₂ (5). Density functional theory calculations provide support for the synthetic mechanism and proposed intermediates. The metal/ligand-to-ligand charge-transfer (ML-LCT) absorption maximum of the trans complex 4 at 832 nm is red-shifted by 1173 cm^-1 and exhibits shorter lifetimes of the ¹ML-LCT and ³ML-LCT excited states, 3 ps and 0.40 ns, respectively, compared to those of the cis analogue 5. The shorter excited-state lifetimes of 4 are attributed to the longer Rh-Rh bond of 2.4942(8) Å relative to that in 5, 2.4498(2) Å. A longer metal-metal bond reflects a decreased overlap of the Rh atoms, which leads to more accessible metal-centered excited states for radiationless deactivation. The ³ML-LCT excited states of 4 and 5 undergo reversible bimolecular charge transfer with the electron donor p-phenylenediamine when irradiated with low-energy light. These results indicate that trans isomers are a source of unexplored tunability for potential p-type semiconductor applications and, given their distinct geometric arrangement, constitute useful building blocks for supramolecular architectures with potentially interesting photophysical properties.

Two Four-Coordinate and Seven-Coordinate CoII Complexes Based on the Bidentate Ligand 1, 8-Naphthyridine Showing Slow Magnetic Relaxation Behavior

For a long time, the cobalt(II) complex ([Co(napy)₄ ](ClO₄ )₂ ) (napy=1, 8-naphthyridine) has been considered as an eight-coordinate complex without any structural proof. After careful considerations, two complexes [Co(napy)₂ Cl₂ ] (1) and [Co(napy)₄ ](ClO₄ )₂ (2) based on the bidentate ligand napy were synthesized and structurally characterized. X-ray single-crystal structural determination showed that the cobalt(II) center in [Co(napy)₂ Cl₂ ] (1) is four-coordinate with a tetrahedral geometry (T_d ), while [Co(napy)₄ ](ClO₄ )₂ (2) is seven-coordinate rather than eight-coordinate with a capped trigonal prism geometry (C_2v ). Direct-current (dc) magnetic data revealed that complexes 1 and 2 possess positive zero-field splitting (ZFS) parameters of 11.08 and 25.30 cm^-1 , respectively, with easy-plane magnetic anisotropy. Alternating current(ac) susceptibility measurements revealed that both complexes showed slow magnetic relaxation behaviour. Theoretical calculations demonstrated that the presence of easy-plane magnetic anisotropy (D>0) for complexes 1 and 2 is in agreement with the experimental data. Furthermore, these results pave the way to obtain four-coordinate and seven-coordinate cobalt(II) single-ion magnets (SIMs) by using a bidentate ligand.

Reactions of Rh2(CH3COO)4 with thiols and thiolates: a structural study

The structural differences between the aerobic reaction products of Rh2(AcO)4 (1; AcO- = CH3COO-) with thiols and thiolates in non-aqueous media are probed by X-ray absorption spectroscopy. For this study, ethanethiol, dihydrolipoic acid (DHLA; a dithiol) and their sodium thiolate salts were used. Coordination of simple thiols to the axial positions of Rh2(AcO)4 with Rh-SH bonds of 2.5-2.6 Å keeps the RhII-RhII bond intact (2.41 ± 0.02 Å) but leads to a colour change from emerald green to burgundy. Time-dependent density functional theory (TD-DFT) calculations were performed to explain the observed shifts in the electronic (UV-vis) absorption spectra. The corresponding sodium thiolates, however, break up the Rh2(AcO)4 framework in the presence of O2 to form an oligomeric chain of triply S-bridged Rh(III) ions, each with six Rh-S (2.36 ± 0.02 Å) bonds. The RhIII...RhIII distance, 3.18 ± 0.02 Å, in the chain is similar to that previously found for the aerobic reaction product from aqueous solutions of Rh2(AcO)4 and glutathione (H3A), {Na2[Rh2III(HA)4]·7H2O}n, in which each Rh(III) ion is surrounded by about four Rh-S (2.33 ± 0.02 Å) and about two Rh-O (2.08 ± 0.02 Å). The reaction products obtained in this study can be used to predict how dirhodium(II) tetracarboxylates would react with cysteine-rich proteins and peptides, such as metallothioneins.

Rhodium at the chemistry-biology interface

As a rare element with no known natural biological function, rhodium has a limited history in biological chemistry and chemical biology. However, rhodium complexes have unique structure and reactivity attributes, and chemists have increasingly used these attributes to probe and perturb living systems. This brief review focuses on recent advances in the use of rhodium complexes in biological contexts, including medicinal chemistry, protein science, and chemical biology. In particular, we highlight both structure- and reactivity-driven approaches to biological probes and discuss how coordination environment affects molecular properties in a biological environment.

Nuclear localization of dirhodium(ii) complexes in breast cancer cells by X-ray fluorescence microscopy

X-ray fluorescence microscopy confirms the necessity of vacant axial sites in dirhodium(ii) carboxylates for their cellular uptake and cytotoxicity.

Methionine Binding to Dirhodium(II) Tetraacetate

The reaction between antitumor active dirhodium(II) tetraacetate and dl-methionine (HMet) was followed in aqueous solution and showed initially mixtures of 1:1 and 1:2 adducts [Rh2(AcO)4(HMet)(H2O)] (AcO- = CH3COO-) and [Rh2(AcO)4(HMet)2] formed at room temperature (RT), as evidenced by UV-vis spectroscopy and electrospray ionization mass spectrometry (ESI-MS). Rh K-edge extended X-ray absorption fine structure (EXAFS) spectroscopy confirmed methionine thioether binding to the axial positions of the Rh2(AcO)4 cage structure. With excess HMet at RT, stepwise displacement of the acetate groups was observed after some time using ESI-MS. Heating the solution to 40° for 24 h accelerated the substitution reaction leading to stable dirhodium(II) species with two acetate ligands displaced by two methionine groups. The crystal structure of the purple [RhII2(AcO)2(d-Met)(l-Met)]·6H2O compound obtained from the solution revealed tridentate coordination of the methionine ligands to the Rh(II) ions, with the thioether S atoms in equatorial positions. A minor amount of a light orange monomeric [RhIII(Met)2](AcO) complex also formed in the solution was isolated by size exclusion chromatography and identified by ESI-MS. Crystals of [RhIII(d-Met)(l-Met)]Cl·3H2O were prepared by reacting RhCl3 and dl-HMet. The crystal structure showed tridentate binding of the methionine ligands to the Rh(III) ion in a trans-S, N, O arrangement.

Tunable Rh2(II,II) Light Absorbers as Excited-State Electron Donors and Acceptors Accessible with Red/Near-Infrared Irradiation

A series of dirhodium(II,II) paddlewheeel complexes of the type cis-[Rh₂(μ-DTolF)₂(μ-L)₂][BF₄]₂, where DTolF = N,N'-di( p-tolyl)formamidinate and L = 1,8-naphthyridine (np), 2-(pyridin-2-yl)-1,8-naphthyridine (pynp), 2-(quinolin-2-yl)-1,8-naphthyridine (qnnp), and 2-(1,8-naphthyridin-2-yl)quinoxaline (qxnp), were synthesized and characterized. These molecules feature new tridentate ligands that concomitantly bridge the dirhodium core and cap the axial positions. The complexes absorb light strongly throughout the ultraviolet/visible range and into the near-infrared region and exhibit relatively long-lived triplet excited-state lifetimes. Both the singlet and triplet excited states exhibit metal/ligand-to-ligand charge transfer (ML-LCT) in nature as determined by transient absorption spectroscopy and spectroelectrochemistry measurements. When irradiated with low-energy light, these black dyes are capable of undergoing reversible bimolecular electron transfer both to the electron acceptor methyl viologen and from the electron donor p-phenylenediamine. Photoinduced charge transfer in the latter was inaccessible with previous Rh₂(II,II) complexes. These results underscore the fact that the excited state of this class of molecules can be readily tuned for electron-transfer reactions upon simple synthetic modification and highlight their potential as excellent candidates for p- and n-type semiconductor applications and for improved harvesting of low-energy light to drive useful photochemical reactions.

Cationic dirhodium(ii,ii) complexes for the electrocatalytic reduction of CO2 to HCOOH

Two formamidinate bridged dirhodium(ii,ii) complexes with chelating diimine ligands L, [Rh₂(μ-DTolF)₂(L)₂]²⁺, were shown to electrocatalytically reduce CO₂ in the presence of H₂O. Analysis of the reaction mixture and headspace following bulk electrolysis revealed H₂ and HCOOH as the major products. The variation in relative product formation is discussed.

An experimental and quantum chemical study on the non-covalent interactions of a cyclometallated Rh(iii) complex with DNA and BSA

The interaction of a new cyclometallated Rh(iii) complex with DNA and BSA was investigated. The three-layer ONIOM method was employed to calculate the interaction energy between DNA and the complex.

Photoinduced interactions of two dirhodium complexes with d(GTCGAC)2 probed by 2D NOESY

The interactions between the 6-mer duplex oligonucleotide d(GTCGAC)2 and the photoactive dirhodium complexes cis-H,H-[Rh2(HNOCCH3)2(L)(CH3CN)4](2+), where L represents bpy (1, 2,2'-bipyridine) and dppz (2, dipyrido[3,2-a:2',3'-c]phenazine), were probed using 2D (1)H-(1)H NOESY NMR spectroscopy. Complex does not interact with the duplex in the dark, but binds covalently to the terminal guanine following irradiation with visible light. Similar behavior was observed for 2, but in addition to the photoinduced covalent DNA binding, the planar dppz ligand of the complex shields the terminal cytosine protons after irradiation. The results are consistent with photoinduced guanine coordination and end-capping of the duplex through π-stacking interactions with the terminal GC base pair. These data show that in the presence of the 6-mer duplex oligonucleotide, 1 and 2 exhibit photoinduced covalent binding to DNA. In addition, the π-stacking interactions of 2 with the duplex are enhanced upon irradiation.

An in vitro enzymatic assay to measure transcription inhibition by gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles

Chemotherapy often involves broad-spectrum cytotoxic agents with many side effects and limited targeting. Corroles are a class of tetrapyrrolic macrocycles that exhibit differential cytostatic and cytotoxic properties in specific cell lines, depending on the identities of the chelated metal and functional groups. The unique behavior of functionalized corroles towards specific cell lines introduces the possibility of targeted chemotherapy. Many anticancer drugs are evaluated by their ability to inhibit RNA transcription. Here we present a step-by-step protocol for RNA transcription in the presence of known and potential inhibitors. The evaluation of the RNA products of the transcription reaction by gel electrophoresis and UV-Vis spectroscopy provides information on inhibitive properties of potential anticancer drug candidates and, with modifications to the assay, more about their mechanism of action. Little is known about the molecular mechanism of action of corrole cytotoxicity. In this experiment, we consider two corrole compounds: gallium(III) 5,10,15-(tris)pentafluorophenylcorrole (Ga(tpfc)) and freebase analogue 5,10,15-(tris)pentafluorophenylcorrole (tpfc). An RNA transcription assay was used to examine the inhibitive properties of the corroles. Five transcription reactions were prepared: DNA treated with Actinomycin D, triptolide, Ga(tpfc), tpfc at a [complex]:[template DNA base] ratio of 0.01, respectively, and an untreated control. The transcription reactions were analyzed after 4 hr using agarose gel electrophoresis and UV-Vis spectroscopy. There is clear inhibition by Ga(tpfc), Actinomycin D, and triptolide. This RNA transcription assay can be modified to provide more mechanistic detail by varying the concentrations of the anticancer complex, DNA, or polymerase enzyme, or by incubating the DNA or polymerase with the complexes prior to RNA transcription; these modifications would differentiate between an inhibition mechanism involving the DNA or the enzyme. Adding the complex after RNA transcription can be used to test whether the complexes degrade or hydrolyze the RNA. This assay can also be used to study additional anticancer candidates.

Structure-activity relationship of polypyridyl ruthenium(II) complexes as DNA intercalators, DNA photocleavage reagents, and DNA topoisomerase and RNA polymerase inhibitors

To investigate the relationship between the molecular structure and biological activity of polypyridyl Ru(II) complexes, such as DNA binding, photocleavage ability, and DNA topoisomerase and RNA polymerase inhibition, six new [Ru(bpy)(2)(dppz)](2+) (bpy=2,2'-bipyridine; dppz=dipyrido[3,2-a:2,',3'-c]phenazine) analogs have been synthesized and characterized by means of (1)H-NMR spectroscopy, mass spectrometry, and elemental analysis. Interestingly, the biological properties of these complexes have been identified to be quite different via a series of experimental methods, such as spectral titration, DNA thermal denaturation, viscosity, and gel electrophoresis. To explain the experimental regularity and reveal the underlying mechanism of biological activity, the properties of energy levels and population of frontier molecular orbitals and excited-state transitions of these complexes have been studied by density-functional theory (DFT) and time-depended DFT (TDDFT) calculations. The results suggest that DNA intercalative ligands with better planarity, greater hydrophobicity, and less steric hindrance are beneficial to the DNA intercalation and enzymatic inhibition of their complexes.

Photoinduced ligand exchange and DNA binding of cis-[Ru(phpy)(phen)(CH3CN)2]+ with long wavelength visible light

The complex cis-[Ru(phpy)(phen)(CH3CN)2](+) (phpy=2-phenylpyridine, phen=1,10-phenanthroline) was investigated as a potential photodynamic therapy (PDT) agent. This complex presents desirable photochemical characteristics including a low energy absorption tail extending into the PDT window (600-850nm) and photoinduced exchange of the CH3CN ligands, generating a species analogous to the chemotherapy drug cisplatin. Furthermore, photochemical reactivity can be controlled through selective irradiation into the Ru-phen singlet metal-to-ligand charge transfer ((1)MLCT) band (λirr=500 nm) of [Ru(phpy)(phen)(CH3CN)2](+) in the presence of excess t-butylammonium chloride (TBACl) resulting in efficient photoinduced production of [Ru(phpy)(phen)(CH3CN)Cl] (Φ=0.25). This lower energy irradiation resulted in greater quantum yield of photosubstitution when compared to direct irradiation into the Ru-phpy (1)MLCT peak (λirr=450 nm; Φ=0.08) in CH2Cl2. It was found that the lower quantum yield observed for irradiation into the Ru→phpy(-)(1)MLCT band results from significant orbital mixing of the phpy(-) ligand with the t2g-type filled set in the metal, giving this state significant ligand-centered character. Lastly, this complex produced a decrease in the mobility of linearized ds-DNA when irradiated with λirr≥420nm, indicative of covalent binding by the transition metal complex similar to that observed for cisplatin. No change in mobility was found for the same samples kept in the dark indicating, unlike cisplatin, DNA binding of cis-[Ru(phpy)(phen)(CH3CN)2](+) only occurs with the activation of light. These observations support the use of cis-[Ru(phpy)(phen)(CH3CN)2](+) as a potential PDT agent by the photoinduced generation of a cisplatin analog.

Enantiomer recognition of amides by dirhodium(II) tetrakis[methyl 2-oxopyrrolidine-5(S)-carboxylate]

Association constants of the chiral dirhodium(II) carboxamidate Rh(2)(5S-MEPY)(4) with Lewis bases including acetonitrile and amides have been determined by UV-vis titration experiments. With chiral lactams and acyclic acetamides in their R- and S-configurations equilibrium constants with chiral dirhodium carboxamidates are measures of chiral differentiation, and equilibrium constant ratios as high as three have been determined. From equilibrium associations with acetamide, N-methylacetamide, and N,N-dimethylacetamide, as well as equilibrium constants for lactams and acyclic amides, higher values occur when both the amide carbonyl oxygen and N-H are bound to Rh(2)(5S-MEPY)(4). This cooperative bonding mode is confirmed by NMR measurements that show a distinctive shift of a N-H absorption, as well as perturbation of the ligands on dirhodium compound, and they suggest N-H association with a ligated oxygen of Rh(2)(5S-MEPY)(4). Measurements were made on the dirhodium(II) compound from which protective axial ligands have been removed to enhance their reliability.

Live cell cytotoxicity studies: documentation of the interactions of antitumor active dirhodium compounds with nuclear DNA

The promising antitumor activity of dirhodium complexes has been known for over 30 years. There remains, however, a general lack of understanding of their activity in cellulo. In this study, we report the DNA interactions and activity in living cells of six monosubstituted dirhodium(II,II) complexes of general formula [Rh(2)(mu-O(2)CCH(3))(2)(eta(1)-O(2)CCH(3))(L)(CH(3)OH)](+), where L = bpy (2,2'-bipyridine) (1), phen (1,10-phenanthroline) (2), dpq (dipyrido[3,2-f:2',3'-h]quinoxaline) (3), dppz (dipyrido[3,2-a:2',3'-c]phenazine) (4), dppn (benzo[i]dipyrido[3,2-a:2',3'-c]phenazine) (5), and dap (4,7-dihydrodibenzo[de,gh][1,10]phenanthroline) (6). DNA interactions were investigated by UV/visible spectroscopy, relative viscosity measurements, and electrophoretic mobility shift assay. These measurements indicate that compound 5 exhibits the strongest interaction with DNA. Compound 5 also causes the most damage to DNA after cellular internalization, as evaluated by the alkaline comet assay. Compound 5, however, is not the most effective at inhibiting cell viability of the human cancer cells HeLa and COLO-316. The greater hydrophobicity of 5 as compared to that of 4, which is the most effective compound in the series, hinders its ability to reach its cellular target(s). Data from modulation studies of glutathione using N-acetylcysteine and L-buthionine-sulfoximine indicate that changes in glutathione levels do not affect the activity of these particular dirhodium complexes. These results suggest that glutathione is not the only agent involved in the deactivation of these dirhodium complexes.

Anticancer activity of heteroleptic diimine complexes of dirhodium: a study of intercalating properties, hydrophobicity and in cellulo activity

The series of complexes cis-[Rh(2)(mu-O(2)CCH(3))(2)(dppn)(L)](2+), where dppn = benzo[i]dipyrido[3,2-a:2',3'-c] phenazine, and L = bpy (2,2'-bipyridine) (1), phen (1,10-phenanthroline) (2), dpq (dipyrido[3,2-f:2',3'-h]quinoxaline) (3), dppz (dipyrido[3,2-a:2',3'-c]phenazine) (4), and dppn (5) were synthesized and their effect on the human cancer cells HeLa and COLO-316 was monitored. Complexes 1 and 2 interact with DNA through intercalation, whereas compounds 3-5 bind only electrostatically. It was found that the dirhodium complex 4 is the most effective compound at inhibiting cell viability of the human cancer cells HeLa and COLO-316. A general conclusion is that the hydrophobicity of the compounds correlates with their in cellulo activity in both cell lines. The ability of the compounds to reach nuclear DNA and form adducts was explored using the comet assay. The results indicate that compounds 1-5 either do not form adducts with DNA that are detrimental to the cell or that they are successfully repaired by the cellular machinery. The results of an annexin V assay indicate that compounds 1-4 trigger apoptosis, whereas compound 5 clearly does not. These findings are significant because they support the contention that dirhodium complexes can be tuned to direct their effect to cellular targets other than nuclear DNA.

DNA interactions and photocatalytic strand cleavage by artificial nucleases based on water-soluble gold(III) porphyrins

The novel gold porphyrin complex (5,10,15-tris(N-methylpyridinium-4-yl)-20-(1-pyrenyl)-porphyrinato)gold(III) chloride, [Au(III)(TMPy3Pyr1P)]Cl4, was prepared and characterized by optical spectroscopy, high-resolution nuclear magnetic resonance (NMR), and electrospray mass spectrometry. This cationic multichromophore compound exhibits excellent water solubility and does not form aggregates under physiological conditions. Binding interactions of this complex and related model compounds with nucleic acid substrates have been studied and characterized by NMR and circular dichroism spectroscopy. The photoreactivity of [Au(III)(TMPy3Pyr1P)]Cl4 was investigated under anaerobic and aerobic conditions in the presence of an excess of purine nucleoside, guanosine, and plasmid DNA. Photocatalytic oxidative degradation of guanosine and the change from supercoiled to circular plasmid DNA upon monochromatic irradiation and polychromatic blue-light exposure with a maximum at 420 nm was explored. The potential of the novel water-soluble cationic metallointercalator complex [Au(III)(TMPy3Pyr1P)]Cl4 to serve as a catalytic photonuclease for the cleavage of DNA has been demonstrated.